267 related articles for article (PubMed ID: 33785559)
1. Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting
Dong X; Song S; Li Y; Fan Y; Wang L; Wang R; Huo L; Scott A; Xu Y; Pizzi MP; Ma L; Wang Y; Jin J; Zhao W; Yao X; Johnson RL; Wang L; Wang Z; Peng G; Ajani JA
Gut; 2022 Mar; 71(3):467-478. PubMed ID: 33785559
[TBL] [Abstract][Full Text] [Related]
2. ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice.
Kimura Y; Fukuda A; Ogawa S; Maruno T; Takada Y; Tsuda M; Hiramatsu Y; Araki O; Nagao M; Yoshikawa T; Ikuta K; Yoshioka T; Wang Z; Akiyama H; Wright CV; Takaori K; Uemoto S; Chiba T; Seno H
Gastroenterology; 2018 Jul; 155(1):194-209.e2. PubMed ID: 29604291
[TBL] [Abstract][Full Text] [Related]
3. Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1.
Zhong Q; Wang HG; Yang JH; Tu RH; Li AY; Zeng GR; Zheng QL; Yu Liu Z; Shang-Guan ZX; Bo Huang X; Huang Q; Li YF; Zheng HL; Lin GT; Huang ZN; Xu KX; Qiu WW; Jiang MC; Zhao YJ; Lin JX; Huang ZH; Huang JM; Li P; Xie JW; Zheng CH; Chen QY; Huang CM
Adv Sci (Weinh); 2023 Nov; 10(32):e2301977. PubMed ID: 37824217
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1.
Zhang Q; Yan HB; Wang J; Cui SJ; Wang XQ; Jiang YH; Feng L; Yang PY; Liu F
Oncotarget; 2016 Jul; 7(29):46127-46141. PubMed ID: 27323812
[TBL] [Abstract][Full Text] [Related]
5. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
Abe H; Maeda D; Hino R; Otake Y; Isogai M; Ushiku AS; Matsusaka K; Kunita A; Ushiku T; Uozaki H; Tateishi Y; Hishima T; Iwasaki Y; Ishikawa S; Fukayama M
Virchows Arch; 2012 Oct; 461(4):367-77. PubMed ID: 22915242
[TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O
Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506
[TBL] [Abstract][Full Text] [Related]
7. Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer.
Yamada L; Saito M; Thar Min AK; Saito K; Ashizawa M; Kase K; Nakajima S; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Kono K
Gastric Cancer; 2021 Jan; 24(1):60-71. PubMed ID: 32506298
[TBL] [Abstract][Full Text] [Related]
8. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
[TBL] [Abstract][Full Text] [Related]
9. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
10. ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer.
Sato T; Saito M; Nakajima S; Saito K; Katagata M; Fukai S; Okayama H; Sakamoto W; Saze Z; Momma T; Mimura K; Kono K
Gastric Cancer; 2023 May; 26(3):379-392. PubMed ID: 36811690
[TBL] [Abstract][Full Text] [Related]
11. Methionine and leucine induce ARID1A degradation to promote mTOR expression and milk synthesis in mammary epithelial cells.
Qi H; Wang L; Zhang M; Wang Z; Gao X; Li M
J Nutr Biochem; 2022 Mar; 101():108924. PubMed ID: 34843932
[TBL] [Abstract][Full Text] [Related]
12. Various ARID1A expression patterns and their clinical significance in gastric cancers.
Kim YB; Ham IH; Hur H; Lee D
Hum Pathol; 2016 Mar; 49():61-70. PubMed ID: 26826411
[TBL] [Abstract][Full Text] [Related]
13. DAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway.
Dai L; Zhuang L; Zhang B; Wang F; Chen X; Xia C; Zhang B
Int J Mol Sci; 2015 Dec; 16(12):28510-22. PubMed ID: 26633375
[TBL] [Abstract][Full Text] [Related]
14. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
Fan Y; Li Y; Yao X; Jin J; Scott A; Liu B; Wang S; Huo L; Wang Y; Wang R; Pool Pizzi M; Ma L; Shao S; Sewastjanow-Silva M; Waters R; Chatterjee D; Liu B; Shanbhag N; Peng G; Calin GA; Mazur PK; Hanash SM; Ishizawa J; Hirata Y; Nagano O; Wang Z; Wang L; Xian W; McKeon F; Ajani JA; Song S
Gut; 2023 Apr; 72(4):624-637. PubMed ID: 36002248
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
Wang DD; Chen YB; Pan K; Wang W; Chen SP; Chen JG; Zhao JJ; Lv L; Pan QZ; Li YQ; Wang QJ; Huang LX; Ke ML; He J; Xia JC
PLoS One; 2012; 7(7):e40364. PubMed ID: 22808142
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
17. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.
Kim AL; Back JH; Chaudhary SC; Zhu Y; Athar M; Bickers DR
J Invest Dermatol; 2018 Aug; 138(8):1716-1725. PubMed ID: 29550418
[TBL] [Abstract][Full Text] [Related]
18. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
[TBL] [Abstract][Full Text] [Related]
19. PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway.
Xing X; Zhang L; Wen X; Wang X; Cheng X; Du H; Hu Y; Li L; Dong B; Li Z; Ji J
Anticancer Drugs; 2014 Nov; 25(10):1129-40. PubMed ID: 25035961
[TBL] [Abstract][Full Text] [Related]
20. Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways.
Syu LJ; Zhao X; Zhang Y; Grachtchouk M; Demitrack E; Ermilov A; Wilbert DM; Zheng X; Kaatz A; Greenson JK; Gumucio DL; Merchant JL; di Magliano MP; Samuelson LC; Dlugosz AA
Oncotarget; 2016 Mar; 7(9):10255-70. PubMed ID: 26859571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
